Vitamin D Deficiency is Associated With Increased Plasminogen Activator Inhibitor 1/Plasminogen Activator Inhibitor 2 Ratio in Pregnancy.

"The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: ALV is the primary investigator of a larger double-blinded randomized controlled trial (the GRAVITD trial) investigating the effect of increased vitamin supplementation during pregnancy, for which vitamin D and placebo tablets have been donated by Orkla Care Denmark. Orkla Care Denmark had no role in any part of either the GRAVITD trial or the present study."

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Frimodt-Heineke Fonden, Murermester Lauritz Peter Christensen og hustru Kirsten Sigrid Christensens Fond, Regionshopitalet Randers’ spiremidler 2020, Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Fond (grant number 3051415 jhj/mj/is). The funding sources played no role in neither study design, data collection, data analysis, interpretation of data, nor in the writing of the manuscript."